RESUMO
BACKGROUND: The efficacy and safety of high versus medium doses of glucocorticoids for the treatment of patients with COVID-19 has shown mixed outcomes in controlled trials and observational studies. We aimed to evaluate the effectiveness of methylprednisolone 250 mg bolus versus dexamethasone 6 mg in patients with severe COVID-19. METHODS: A randomised, open-label, controlled trial was conducted between February and August 2021 at four hospitals in Spain. The trial was suspended after the first interim analysis since the investigators considered that continuing the trial would be futile. Patients were randomly assigned in a 1:1 ratio to receive dexamethasone 6 mg once daily for up to 10 days or methylprednisolone 250 mg once daily for 3 days. RESULTS: Of the 128 randomised patients, 125 were analysed (mean age 60 ± 17 years; 82 males [66%]). Mortality at 28 days was 4.8% in the 250 mg methylprednisolone group versus 4.8% in the 6 mg dexamethasone group (absolute risk difference, 0.1% [95% CI, -8.8 to 9.1%]; p = 0.98). None of the secondary outcomes (admission to the intensive care unit, non-invasive respiratory or high-flow oxygen support, additional immunosuppressive drugs, or length of stay), or prespecified sensitivity analyses were statistically significant. Hyperglycaemia was more frequent in the methylprednisolone group at 27.0 versus 8.1% (absolute risk difference, -18.9% [95% CI, -31.8 to - 5.6%]; p = 0.007). CONCLUSIONS: Among severe but not critical patients with COVID-19, 250 mg/d for 3 days of methylprednisolone compared with 6 mg/d for 10 days of dexamethasone did not result in a decrease in mortality or intubation.
Assuntos
COVID-19 , Adulto , Masculino , Humanos , Pessoa de Meia-Idade , Idoso , Metilprednisolona , SARS-CoV-2 , Dexametasona , Resultado do TratamentoRESUMO
Acute carbon monoxide (CO) intoxication may result in delayed neurological sequelae, which can include amnesia, ataxia, aphasia, emotional lability, disorientation, dysphagia, and other manifestations. A 27-year-old man reported symptoms of aphasia with agraphia and alexia in a review after CO intoxication. The patient received outpatient speech therapy, as well as repeated sessions of hyperbaric oxygen for 15 days, interspersing speech therapy with hyperbaric oxygen therapy for two months. After this period of combined treatment the aphasic symptomatology remitted, and oral and written language was normal. The complete disappearance of aphasia with agraphia and alexia confirms the efficacy of the combined intervention. More data from large clinical studies are needed to assess the outcomes of hyperbaric oxygen treatment in patients with delayed neurological sequelae after CO intoxication, but this case suggests it may be a good therapeutic option in combination with specific speech therapy.
Assuntos
Agrafia , Afasia , Intoxicação por Monóxido de Carbono , Dislexia , Oxigenoterapia Hiperbárica , Masculino , Humanos , Adulto , Monóxido de Carbono , Agrafia/complicações , Agrafia/terapia , Fonoterapia , Afasia/complicações , Afasia/terapia , Intoxicação por Monóxido de Carbono/complicações , Dislexia/complicações , Dislexia/terapiaRESUMO
BACKGROUND: Since the first cases of COVID-19 were reported in Wuhan, the nutritional status of individuals infected with the virus has not been included in the risk profiles prepared. However, nutritional status, along with other factors, is decisive in the evolution of patients with other infectious diseases. The nutritional status of individuals is considered an indicator of health status. Furthermore, optimal nutritional status transcends the individual, and poor diet in a population can be considered a group risk factor. Evidence exists on the influence that diet has on the immune system and susceptibility to disease. OBJECTIVE: To evaluate the nutritional status of patients older than 65 years who were admitted due to COVID-19 and how this has influenced the evolution of patients. DESIGN: This prospective and observational study was performed in patients with COVID-19 infection confirmed by real-time polymerase chain reaction. Data were collected from the first 24 h of admission. All patients admitted during one month to the wards assigned to COVID-19 infection were included. RESULTS: A total of 83 patients were studied. The statistical study of mortality showed associations with age (p = .005), living in a nursing home (p = .022), a high Charlson Comorbidity Index (p = .039), hypertension (p = .032), comorbidities of dementia (p = .019) and cerebral vascular disease (p = .041), and Barthel Index (p = .010). The analysis of the influence of the nutritional state on mortality revealed a statistical association between malnutrition and mortality in the pooled data analysis (p = .005) and analysis by degrees of malnutrition (p = .27). CONCLUSIONS: Malnutrition was a risk factor as powerful as others such as hypertension, age, and different comorbidities. We must evaluate and treat the nutritional status of elderly patients with COVID-19 infection since it directly affects their evolution.
Assuntos
COVID-19/etiologia , Desnutrição/complicações , Estado Nutricional , SARS-CoV-2 , Idoso , Idoso de 80 Anos ou mais , COVID-19/metabolismo , COVID-19/mortalidade , Feminino , Humanos , Masculino , Estudos Prospectivos , Fatores de RiscoAssuntos
Demência/complicações , Nutrição Enteral/instrumentação , Nutrição Enteral/métodos , Transtornos da Alimentação e da Ingestão de Alimentos/etiologia , Transtornos da Alimentação e da Ingestão de Alimentos/terapia , Gastrostomia , Intubação Gastrointestinal , Humanos , Guias de Prática Clínica como AssuntoAssuntos
Ferro , Pacientes Ambulatoriais , Assistência Ambulatorial , Humanos , Atenção Primária à SaúdeRESUMO
No disponible
Assuntos
Humanos , Pessoa de Meia-Idade , Infecções por Clostridium/diagnóstico , Fatores de Risco , Clostridioides difficile/isolamento & purificação , Infecções por Clostridium/tratamento farmacológico , Metronidazol/administração & dosagem , Vancomicina/administração & dosagemRESUMO
No disponible
Assuntos
Humanos , Ferro/uso terapêutico , Administração Intravenosa/métodos , Comunicação Interdisciplinar , Adjuvantes FarmacêuticosRESUMO
No disponible